HAEMOPHILIA A
Clinical trials for HAEMOPHILIA A explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug Mim8 aims to prevent bleeds in hemophilia a patients
Disease control OngoingThis study tests the long-term safety and effectiveness of a new medicine called Mim8 in people with hemophilia A, including those whose bodies have developed inhibitors to standard treatment. Mim8 helps replace the missing clotting factor to prevent bleeding episodes. About 451 …
Matched conditions: HAEMOPHILIA A
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 17, 2026 13:57 UTC
-
Hemophilia drug esperoct under Long-Term safety watch
Disease control ENROLLING_BY_INVITATIONThis study follows about 60 males with hemophilia A who are already using Esperoct to prevent bleeding. Researchers will track side effects and how well the drug controls bleeds over 5-7 years. Participants receive their usual care, with no new treatments or extra procedures beyo…
Matched conditions: HAEMOPHILIA A
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 04, 2026 16:17 UTC
-
Researchers track side effects of Blood-Clotting drug in haemophilia patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study gathers safety information from a European registry about the drug turoctocog alfa pegol, used to treat haemophilia A. Researchers will count and analyze side effects reported by patients already in the registry. No extra visits or tests are required from participants.
Matched conditions: HAEMOPHILIA A
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated May 17, 2026 13:58 UTC